Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
325 participants
INTERVENTIONAL
2011-08-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will use a randomized controlled trial (RCT) design to test a clinical intervention at TriHealth Good Samaritan Hospital. Study participants will be randomized to the intervention group (IG), which will implement mother-baby Skin-to-Skin (STS) immediately after vaginal birth, or to the control group (CG), which will receive standard care for newborn and mother immediately after vaginal birth.
This study will test the hypothesis that mother-baby STS contact implemented immediately after delivery for a minimum of the newborn's first 60 minutes and with a resumption of STS (if a 15-minute break in STS occurs at some point after the first hour) until the newborn's temperature stabilizes after the initial bath will result in:
1. Improved newborn temperature stability and thermoregulation for newborns whether breast or formula-fed.
2. Initiation of effective breastfeeding behavior within 90 minutes of birth and the addition of at least one more breastfeeding within four hours of birth for breastfed newborns.
3. Avoidance of newborn weight loss of 10% or greater.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Healthy Newborn's Body Temperature at Birth
NCT06275932
Influence of Duration Since Birth Until Admission to Well-baby Nursery on Neonatal Temperature at Admission
NCT05505903
The Effect of Music Therapy on Newborns
NCT03987165
Randomised Controlled Trial on Using Active Warming to Prevent Newborn Hypothermia After Caesarean Delivery
NCT06532266
Immediate Skin-To-Skin Contact and Early Breastfeeding During Caesarean Section
NCT06543160
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Skin to Skin Contact
implement mother-baby Skin-to-Skin contact immediately after vaginal birth
Skin-to-Skin Contact
Standard of Care
standard care for newborn and mother immediately after vaginal birth
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Skin-to-Skin Contact
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* An uncomplicated pregnancy
* Full-term gestation: 38 0/7 weeks
* Single gestation
* Vertex presentation
* Plans to deliver without general anesthesia
* Likelihood of a vaginal delivery
Exclusion Criteria
* An inability to speak or understand English language
* Preterm gestation: 37 6/7 weeks
* A multiple gestation
* Non-vertex presentation
* Plan for delivery with general anesthesia
* Planned Cesarean delivery
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rachel Baker
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rachel Baker
Nurse Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Gromada, MSN, RN
Role: PRINCIPAL_INVESTIGATOR
TriHealth Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Good Samaritan TriHealth Hospital
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11082-11-058
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.